About Renovacor, Inc. (RCOR) β Dividend Analysis 2026
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.
Is RCOR a good dividend investment in 2026?
RCOR offers a 62.50% forward yield with a 50% payout ratio. Strand Safety Score: N/A. The 5-year dividend CAGR of 0% is modest β investors should weigh current income against growth alternatives.
RCOR DRIP calculator β what's the difference?
With DRIP on a $10,000 investment over 10 years, your RCOR portfolio grows to $1.28M vs $72.5K without reinvestment. This is the compound interest effect in action.
RCOR dividend growth history & forecast
RCOR has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 62.50%.
ETFs do not file income statements or cash flow statements. Their dividend safety depends on the underlying index quality, fund methodology, and holdings composition. Use the Holdings page to analyze individual stocks in this fund.
π RCOR Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RCOR.
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― RCOR Income Goal & Break-Even
Dividend Break-Even
2yr
Years for dividends to fully repay your RCOR investment of $3.20/share (πΊπΈ US Taxable (15%) Β· 15.00% tax)
$10K invested Β· 10 Years
Dividends earned (DRIP)
$698.7K
Lost to inflation (2.8% CPI)
β$2.5K
Real purchasing power gain
$696.2K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in RCOR for:
Shares needed
14,118
Capital required
$45,178
Monthly income
$2,000
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π RCOR Dividend Payment Schedule
RCOR pays quarterly β 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
π°
Apr
May
Jun
π°
Jul
Aug
Sep
π°
Oct
Nov
Dec
π°
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
π RCOR vs Healthcare Benchmarks
How RCOR compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yieldβ²+59.70% vs sectorBetter
RCOR
62.50%
avg
2.80%
5Y Dividend CAGRβΌ-6.80% vs sectorBelow avg
RCOR
0.00%
avg
6.80%
Payout Ratioβ²-5.00% vs sectorBetter
RCOR
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RCOR sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ RCOR Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
RTW INVESTMENTS, LP
10 percent owner
J-Other
2022-12-01
3,000,803
β
β
RTW INVESTMENTS, LP
10 percent owner
J-Other
2022-12-01
350,000
β
β
Needham Thomas E. Jr.
director
D-Return
2022-12-01
12,000
β
β
Lau Joan
director
D-Return
2022-12-01
12,000
β
β
GROSSMAN JONAS
director
D-Return
2022-12-01
12,000
β
β
COVINO GREGORY F
director
D-Return
2022-12-01
12,000
β
β
Benz Edward J. JR
director
A-Award
2022-12-01
3,586
β
β
Benz Edward J. JR
director
D-Return
2022-12-01
12,000
β
β
Amusa Gbolahan
director
D-Return
2022-12-01
12,000
β
β
Killeen Matthew
officer: Chief Scientific Officer
D-Return
2022-12-01
10,550
β
β
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
π About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RCOR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β